Epsilogen Ltd

Epsilogen Ltd

Biotechnology United Kingdom 30 employees
Employees
30
Contacts
2
Emails
2

Epsilogen Ltd Overview

Headquarters
United Kingdom
Phone Number
Available in AeroLeads
Website
epsilogen.com
Industry
Biotechnology
Employees
30
Founded
2016
Funding
16.3M
Company Email
Available in AeroLeads

About Epsilogen Ltd

Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life. The company's lead programme targets the folate receptor alpha (FR alpha) and an anti-FR alpha IgE antibody is currently in a phase I trial to treat ovarian cancer. This is the world's first IgE therapeutic to enter the clinic.

Epsilogen Ltd Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

Epsilogen Ltd Org Chart

Sample employees and titles
Name Title Contact
Leanne Partington Vice President of Product Development at Epsilogen Ltd
Email
Marianne Uteng Managing Director at Novartis Venture Fund
View
Callum Mckenzie, Ph.d. Principal Scientist at Epsilogen Ltd
View
Rebecca Atkinson-Dell Project Manager - Biopharma & Life Sciences - Expert in Preclinical & Clinical Research, Regulatory Compliance, and Cross-functional Leadership
Email

Employees by Management Level

Individual contributor 5 profiles
Manager 2 profiles
Senior / Lead 2 profiles
Executive 1 profile
VP / Head 1 profile
Director 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 5 5 0

Epsilogen Ltd Tech Stack

Data / AI 5 profiles
Engineering 1 profile

Compare Similar Companies to Epsilogen Ltd